KHP Clinical Lecturer in Obstetrics & Gynaecology | RCOG GHTC Member | Committed to improving outcomes for women experiencing hypertension in pregnancy in LMIC
Very proud to share the results of our CRADLE-4 Trial: for women with pre-eclampsia, planned delivery from 34 weeks significantly reduces stillbirth & severe maternal HTN; a critical intervention to save lives in low & lower-middle income countries
https://t.co/m6GWICYAoq
Pre-eclampsia is a leading cause of pregnancy related AKI and both are independently associated with maternal mortality and longer term risk of kidney disease! Please help us to address this neglected and urgent problem by completing and sharing our global survey!
"Trust-Translation-Timing" Delighted to see this paper published - a novel approach to expediting evidence to impact in Zambia & Sierra Leone, based on CRADLE-3 & CRADLE-4 Trials, improving detection & management of pre-eclampsia with communities affected https://t.co/oUvxrR4bmc
Highly recommend this episode - my take home points were: (1) the horrifying number of women with HG who experience suicidal ideation - nearly 7% (2) not being afraid to prescribe ondansetron (3) empowering primary care colleagues and all following the same guideline!
@Nestle - should be ashamed - prioritising profit over infant health in countries where 86% of premature deaths due to non-communicable diseases (obesity a major risk factor) occur https://t.co/KiYB6n0gHD
Honoured to be awarded this opportunity & excited to continue researching ways to improve outcomes for women who experience hypertension in pregnancy in low and middle income countries, alongside an amazing & expanding team!🌍
The KHP Centre for Translational Medicine has awarded five postdoctoral Clinical Research Excellence Fellowships (CREF) including a pharmacist and four doctors, find out more about their exciting projects at https://t.co/Kjw02YlYzN @alicebgray@tasbraithwaite@jm_osullivan
"Pre-eclampsia in our local language, we don’t have it, it’s not there" Our 'Lost in Translation' Study published today explores language barriers to informed consent in Zambia: important lessons for global health researchers & ethics committees @BMJ_Open https://t.co/UkOs04uOID
🩸A single plgf-based test to rule in/out suspected pre-eclampsia ✅
🦜-2 Trial shows no benefit to repeat testing, providing critical new evidence to inform our clinical practice!
📣IMPORTANT STUDY ‼️
A single PlGF test is useful when pre-eclampsia is suspected.
This RCT (22 UK hospitals) looks at REPEAT testing:
- high test performance for needing delivery < 14d for but…
- no reduction in severe adverse outcomes
https://t.co/BgKELLaNSE
This short 10 minute film demonstrates why we should consider routine delivery from 34 weeks in all women with pre-eclampsia. @The_MRC@kingsmedicine . #CRADLE4. @alicebgray https://t.co/uzAmot9hfW
Over the moon to have been awarded 1st Place in the Harold Malkin Prize by @RCObsGyn for the CRADLE-4 Trial showing planned early birth for pre-eclampsia from 34wks in LMICs reduces stillbirth - phenomenal team work and delighted to shine a spotlight on global maternal health!
Thrilled to invite you all to the 1st UK screening of “NEMA’s Choice” at the iconic @RitzyCinema 🤩🎉 on 12th September! A short, powerful documentary by @MariamaWurie_@milesbramdo@KatyK_24 & the @NIHRresearch#CRIBS team in 🇸🇱. 🤰🗯️💡 Let’s talk about pre-eclampsia! 💡🗯️🤰